APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Biologic Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Biologic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173970660326 December 2025195 pages

Choose your research edition.

Industry ResearchBiologic Drugs Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Biologic Drugs Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Biologic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biologic Drugs Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Biologic Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Biologic Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Biologic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biologic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biologic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Biologic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Biologic Drugs include Abbott Laboratories, Amgen, Amgen, Pfizer, Eli Lilly, Roche, Merck & Co., Novartis and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Biologic Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biologic Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biologic Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Biologic Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Biologic Drugs Segment by Company

Abbott Laboratories

Amgen

Amgen

Pfizer

Eli Lilly

Roche

Merck & Co.

Novartis

Johnson & Johnson

Sanofi

Biologic Drugs Segment by Type

Humira

Avastin

Enbrel

Herceptin

Lantus

Remicade

Rituxan

Others

Biologic Drugs Segment by Application

Auto-Immune Diseases

Inflammation

Blood Diseases

Cardiovascular Diseases

Diabetes

Others

Biologic Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biologic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologic Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Biologic Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Biologic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Biologic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Biologic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Biologic Drugs Industry Trends Table 2. Biologic Drugs Industry Drivers Table 3. Biologic Drugs Industry Opportunities and Challenges Table 4. Biologic Drugs Industry Restraints Table 5. Global Biologic Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Biologic Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Biologic Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Biologic Drugs Sales Market Share by Manufacturers Table 9. Global Biologic Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Biologic Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Biologic Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Biologic Drugs Manufacturers, Product Type & Application Table 13. Global Biologic Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Biologic Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Humira Table 17. Major Manufacturers of Avastin Table 18. Major Manufacturers of Enbrel Table 19. Major Manufacturers of Herceptin Table 20. Major Manufacturers of Lantus Table 21. Major Manufacturers of Remicade Table 22. Major Manufacturers of Rituxan Table 23. Major Manufacturers of Others Table 24. Global Biologic Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Biologic Drugs Sales by Type (2021-2026) & (K Units) Table 26. Global Biologic Drugs Sales by Type (2027-2032) & (K Units) Table 27. Global Biologic Drugs Sales Market Share by Type (2021-2026) Table 28. Global Biologic Drugs Sales Market Share by Type (2027-2032) Table 29. Global Biologic Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 30. Global Biologic Drugs Revenue by Type (2021-2026) & (K Units) Table 31. Global Biologic Drugs Revenue by Type (2027-2032) & (K Units) Table 32. Global Biologic Drugs Revenue Market Share by Type (2021-2026) Table 33. Global Biologic Drugs Revenue Market Share by Type (2027-2032) Table 34. Major Manufacturers of Auto-Immune Diseases Table 35. Major Manufacturers of Inflammation Table 36. Major Manufacturers of Blood Diseases Table 37. Major Manufacturers of Cardiovascular Diseases Table 38. Major Manufacturers of Diabetes Table 39. Major Manufacturers of Others Table 40. Global Biologic Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 41. Global Biologic Drugs Sales by Application (2021-2026) & (K Units) Table 42. Global Biologic Drugs Sales by Application (2027-2032) & (K Units) Table 43. Global Biologic Drugs Sales Market Share by Application (2021-2026) Table 44. Global Biologic Drugs Sales Market Share by Application (2027-2032) Table 45. Global Biologic Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 46. Global Biologic Drugs Revenue by Application (2021-2026) & (K Units) Table 47. Global Biologic Drugs Revenue by Application (2027-2032) & (K Units) Table 48. Global Biologic Drugs Revenue Market Share by Application (2021-2026) Table 49. Global Biologic Drugs Revenue Market Share by Application (2027-2032) Table 50. Global Biologic Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 51. Global Biologic Drugs Sales by Region (2021-2026) & (K Units) Table 52. Global Biologic Drugs Sales Market Share by Region (2021-2026) Table 53. Global Biologic Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 54. Global Biologic Drugs Sales Forecasted Market Share by Region (2027-2032) Table 55. North America Biologic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. North America Biologic Drugs Sales by Country (2021-2026) & (K Units) Table 57. North America Biologic Drugs Sales by Country (2027-2032) & (K Units) Table 58. Europe Biologic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. Europe Biologic Drugs Sales by Country (2021-2026) & (K Units) Table 60. Europe Biologic Drugs Sales by Country (2027-2032) & (K Units) Table 61. Asia Pacific Biologic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 62. Asia Pacific Biologic Drugs Sales by Country (2021-2026) & (K Units) Table 63. Asia Pacific Biologic Drugs Sales by Country (2027-2032) & (K Units) Table 64. South America, Middle East and Africa Biologic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 65. South America, Middle East and Africa Biologic Drugs Sales by Country (2021-2026) & (K Units) Table 66. South America, Middle East and Africa Biologic Drugs Sales by Country (2027-2032) & (K Units) Table 67. Global Biologic Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 68. Global Biologic Drugs Revenue by Region (2021-2026) & (US$ Million) Table 69. Global Biologic Drugs Revenue by Region (2027-2032) & (US$ Million) Table 70. Global Biologic Drugs Revenue Market Share by Region (2021-2026) Table 71. Global Biologic Drugs Revenue Market Share by Region (2027-2032) Table 72. Abbott Laboratories Company Information Table 73. Abbott Laboratories Business Overview Table 74. Abbott Laboratories Biologic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Abbott Laboratories Biologic Drugs Product Portfolio Table 76. Abbott Laboratories Recent Development Table 77. Amgen Company Information Table 78. Amgen Business Overview Table 79. Amgen Biologic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Amgen Biologic Drugs Product Portfolio Table 81. Amgen Recent Development Table 82. Amgen Company Information Table 83. Amgen Business Overview Table 84. Amgen Biologic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Amgen Biologic Drugs Product Portfolio Table 86. Amgen Recent Development Table 87. Pfizer Company Information Table 88. Pfizer Business Overview Table 89. Pfizer Biologic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Pfizer Biologic Drugs Product Portfolio Table 91. Pfizer Recent Development Table 92. Eli Lilly Company Information Table 93. Eli Lilly Business Overview Table 94. Eli Lilly Biologic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Eli Lilly Biologic Drugs Product Portfolio Table 96. Eli Lilly Recent Development Table 97. Roche Company Information Table 98. Roche Business Overview Table 99. Roche Biologic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Roche Biologic Drugs Product Portfolio Table 101. Roche Recent Development Table 102. Merck & Co. Company Information Table 103. Merck & Co. Business Overview Table 104. Merck & Co. Biologic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Merck & Co. Biologic Drugs Product Portfolio Table 106. Merck & Co. Recent Development Table 107. Novartis Company Information Table 108. Novartis Business Overview Table 109. Novartis Biologic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Novartis Biologic Drugs Product Portfolio Table 111. Novartis Recent Development Table 112. Johnson & Johnson Company Information Table 113. Johnson & Johnson Business Overview Table 114. Johnson & Johnson Biologic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Johnson & Johnson Biologic Drugs Product Portfolio Table 116. Johnson & Johnson Recent Development Table 117. Sanofi Company Information Table 118. Sanofi Business Overview Table 119. Sanofi Biologic Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Sanofi Biologic Drugs Product Portfolio Table 121. Sanofi Recent Development Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Biologic Drugs Distributors List Table 125. Biologic Drugs Customers List Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Biologic Drugs Product Image Figure 2. Global Biologic Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biologic Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Biologic Drugs Sales (2021-2032) & (K Units) Figure 5. Global Biologic Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Biologic Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Humira Image Figure 9. Avastin Image Figure 10. Enbrel Image Figure 11. Herceptin Image Figure 12. Lantus Image Figure 13. Remicade Image Figure 14. Rituxan Image Figure 15. Others Image Figure 16. Global Biologic Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Biologic Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 18. Global Biologic Drugs Sales Market Share by Type (2021-2032) Figure 19. Global Biologic Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Biologic Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Biologic Drugs Revenue Market Share by Type (2021-2032) Figure 22. Auto-Immune Diseases Image Figure 23. Inflammation Image Figure 24. Blood Diseases Image Figure 25. Cardiovascular Diseases Image Figure 26. Diabetes Image Figure 27. Others Image Figure 28. Global Biologic Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 29. Global Biologic Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 30. Global Biologic Drugs Sales Market Share by Application (2021-2032) Figure 31. Global Biologic Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Biologic Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 33. Global Biologic Drugs Revenue Market Share by Application (2021-2032) Figure 34. North America Biologic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. North America Biologic Drugs Sales Market Share by Country (2021-2032) Figure 36. U.S. Biologic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Canada Biologic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Mexico Biologic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Europe Biologic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Europe Biologic Drugs Sales Market Share by Country (2021-2032) Figure 41. Germany Biologic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. France Biologic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. U.K. Biologic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Italy Biologic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Netherlands Biologic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Asia Pacific Biologic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Asia Pacific Biologic Drugs Sales Market Share by Country (2021-2032) Figure 48. China Biologic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Japan Biologic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Korea Biologic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Southeast Asia Biologic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. India Biologic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Australia Biologic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. South America, Middle East and Africa Biologic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. South America, Middle East and Africa Biologic Drugs Sales Market Share by Country (2021-2032) Figure 56. Brazil Biologic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. South Africa Biologic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Saudi Arabia Biologic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Turkey Biologic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Argentina Biologic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 61. UAE Biologic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 62. Egypt Biologic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 63. Chile Biologic Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 64. Global Biologic Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 65. Global Biologic Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 66. North America Biologic Drugs Revenue (2021-2032) & (US$ Million) Figure 67. North America Biologic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Europe Biologic Drugs Revenue (2021-2032) & (US$ Million) Figure 69. Europe Biologic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Asia-Pacific Biologic Drugs Revenue (2021-2032) & (US$ Million) Figure 71. Asia-Pacific Biologic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 72. South America, Middle East and Africa Biologic Drugs Revenue (2021-2032) & (US$ Million) Figure 73. South America, Middle East and Africa Biologic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 74. Biologic Drugs Value Chain Figure 75. Manufacturing Cost Structure Figure 76. Biologic Drugs Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • Humira
  • Avastin
  • Enbrel
  • Herceptin
  • Lantus
  • Remicade
  • Rituxan
  • Others
Applications
  • Auto-Immune Diseases
  • Inflammation
  • Blood Diseases
  • Cardiovascular Diseases
  • Diabetes
  • Others
Companies covered
  • Abbott Laboratories
  • Amgen
  • Amgen
  • Pfizer
  • Eli Lilly
  • Roche
  • Merck & Co.
  • Novartis
  • Johnson & Johnson
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Biologic Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Biologic Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Biologic Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Biologic Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Biologic Drugs Market Dynamics
  1. 2.1 Biologic Drugs Industry Trends
  2. 2.2 Biologic Drugs Industry Drivers
  3. 2.3 Biologic Drugs Industry Opportunities and Challenges
  4. 2.4 Biologic Drugs Industry Restraints
3 Biologic Drugs Market by Manufacturers
  1. 3.1 Global Biologic Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Biologic Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Biologic Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Biologic Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Biologic Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Biologic Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Biologic Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Biologic Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Biologic Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Biologic Drugs Tier 1, Tier 2, and Tier 3
4 Biologic Drugs Market by Type
  1. 4.1 Biologic Drugs Type Introduction
  2. 4.1.1 Humira
  3. 4.1.2 Avastin
  4. 4.1.3 Enbrel
  5. 4.1.4 Herceptin
  6. 4.1.5 Lantus
  7. 4.1.6 Remicade
  8. 4.1.7 Rituxan
  9. 4.1.8 Others
  10. 4.2 Global Biologic Drugs Sales by Type
  11. 4.2.1 Global Biologic Drugs Sales by Type (2021 VS 2025 VS 2032)
  12. 4.2.2 Global Biologic Drugs Sales by Type (2021-2032)
  13. 4.2.3 Global Biologic Drugs Sales Market Share by Type (2021-2032)
  14. 4.3 Global Biologic Drugs Revenue by Type
  15. 4.3.1 Global Biologic Drugs Revenue by Type (2021 VS 2025 VS 2032)
  16. 4.3.2 Global Biologic Drugs Revenue by Type (2021-2032)
  17. 4.3.3 Global Biologic Drugs Revenue Market Share by Type (2021-2032)
5 Biologic Drugs Market by Application
  1. 5.1 Biologic Drugs Application Introduction
  2. 5.1.1 Auto-Immune Diseases
  3. 5.1.2 Inflammation
  4. 5.1.3 Blood Diseases
  5. 5.1.4 Cardiovascular Diseases
  6. 5.1.5 Diabetes
  7. 5.1.6 Others
  8. 5.2 Global Biologic Drugs Sales by Application
  9. 5.2.1 Global Biologic Drugs Sales by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Biologic Drugs Sales by Application (2021-2032)
  11. 5.2.3 Global Biologic Drugs Sales Market Share by Application (2021-2032)
  12. 5.3 Global Biologic Drugs Revenue by Application
  13. 5.3.1 Global Biologic Drugs Revenue by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Biologic Drugs Revenue by Application (2021-2032)
  15. 5.3.3 Global Biologic Drugs Revenue Market Share by Application (2021-2032)
6 Global Biologic Drugs Sales by Region
  1. 6.1 Global Biologic Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biologic Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Biologic Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Biologic Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Biologic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Biologic Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Biologic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Biologic Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Biologic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Biologic Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Biologic Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Biologic Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Biologic Drugs Revenue by Region
  1. 7.1 Global Biologic Drugs Revenue by Region
  2. 7.1.1 Global Biologic Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Biologic Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Biologic Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Biologic Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Biologic Drugs Revenue (2021-2032)
  8. 7.2.2 North America Biologic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Biologic Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Biologic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Biologic Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Biologic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Biologic Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Biologic Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott Laboratories
  2. 8.1.1 Abbott Laboratories Company Information
  3. 8.1.2 Abbott Laboratories Business Overview
  4. 8.1.3 Abbott Laboratories Biologic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Laboratories Biologic Drugs Product Portfolio
  6. 8.1.5 Abbott Laboratories Recent Developments
  7. 8.2 Amgen
  8. 8.2.1 Amgen Company Information
  9. 8.2.2 Amgen Business Overview
  10. 8.2.3 Amgen Biologic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Amgen Biologic Drugs Product Portfolio
  12. 8.2.5 Amgen Recent Developments
  13. 8.3 Amgen
  14. 8.3.1 Amgen Company Information
  15. 8.3.2 Amgen Business Overview
  16. 8.3.3 Amgen Biologic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Amgen Biologic Drugs Product Portfolio
  18. 8.3.5 Amgen Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Biologic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Biologic Drugs Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Eli Lilly
  26. 8.5.1 Eli Lilly Company Information
  27. 8.5.2 Eli Lilly Business Overview
  28. 8.5.3 Eli Lilly Biologic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Eli Lilly Biologic Drugs Product Portfolio
  30. 8.5.5 Eli Lilly Recent Developments
  31. 8.6 Roche
  32. 8.6.1 Roche Company Information
  33. 8.6.2 Roche Business Overview
  34. 8.6.3 Roche Biologic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Roche Biologic Drugs Product Portfolio
  36. 8.6.5 Roche Recent Developments
  37. 8.7 Merck & Co.
  38. 8.7.1 Merck & Co. Company Information
  39. 8.7.2 Merck & Co. Business Overview
  40. 8.7.3 Merck & Co. Biologic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Merck & Co. Biologic Drugs Product Portfolio
  42. 8.7.5 Merck & Co. Recent Developments
  43. 8.8 Novartis
  44. 8.8.1 Novartis Company Information
  45. 8.8.2 Novartis Business Overview
  46. 8.8.3 Novartis Biologic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Novartis Biologic Drugs Product Portfolio
  48. 8.8.5 Novartis Recent Developments
  49. 8.9 Johnson & Johnson
  50. 8.9.1 Johnson & Johnson Company Information
  51. 8.9.2 Johnson & Johnson Business Overview
  52. 8.9.3 Johnson & Johnson Biologic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Johnson & Johnson Biologic Drugs Product Portfolio
  54. 8.9.5 Johnson & Johnson Recent Developments
  55. 8.10 Sanofi
  56. 8.10.1 Sanofi Company Information
  57. 8.10.2 Sanofi Business Overview
  58. 8.10.3 Sanofi Biologic Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sanofi Biologic Drugs Product Portfolio
  60. 8.10.5 Sanofi Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Biologic Drugs Value Chain Analysis
  2. 9.1.1 Biologic Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Biologic Drugs Production Mode & Process
  6. 9.2 Biologic Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Biologic Drugs Distributors
  9. 9.2.3 Biologic Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst